ylliX - Online Advertising Network
Company Ticker News

Baidu Licenses Its Algorithm To Sanofi For mRNA Vaccine, Therapy Development

Baidu Licenses Its Algorithm To Sanofi For mRNA Vaccine, Therapy Development

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Baidu Inc (NASDAQ: BIDU) has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA (NASDAQ: SNY) for use in designing vaccine and therapeutic products. The deal marks Baidu’s first such commercial deal with a major global drugmaker.

...read full article on Benzinga

ylliX - Online Advertising Network